REGULATED PRESS RELEASE published on 09/05/2024 at 07:01, 13 days 20 hours ago bioMérieux – First-Half 2024 Results
BRIEF published on 08/06/2024 at 17:39, 1 month 12 days ago BioMérieux statement on voting rights in July 2024 Voting Rights BioMérieux Actions AMF Financial Informations
BRIEF published on 08/06/2024 at 17:39, 1 month 12 days ago Déclaration de bioMérieux sur les droits de vote en juillet 2024 Droits De Vote BioMérieux Actions AMF Informations Financières
REGULATED PRESS RELEASE published on 08/06/2024 at 17:34, 1 month 12 days ago Juillet 2024 Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant bioMérieux communique les informations mensuelles sur le nombre total de droits de vote et d'actions au 31/07/2024 conformément aux réglementations financières Droits De Vote BioMérieux Actions Informations Mensuelles Règlementations Financières
BRIEF published on 07/05/2024 at 15:57, 2 months 13 days ago BioMérieux: Information on the number of shares and voting rights in June 2024 Share Capital Voting Rights BioMérieux Actions June 2024
BRIEF published on 07/05/2024 at 15:57, 2 months 13 days ago BioMérieux : Informations sur le nombre d'actions et de droits de vote en juin 2024 Droits De Vote Capital Social BioMérieux Actions Juin 2024
REGULATED PRESS RELEASE published on 07/05/2024 at 15:52, 2 months 13 days ago Juin 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant bioMérieux communique les informations mensuelles sur le nombre total de droits de vote et d'actions. Nombre de droits de vote théoriques : 191 135 911 Droits De Vote BioMérieux Actions Finance Informations Mensuelles
BRIEF published on 06/26/2024 at 07:06, 2 months 22 days ago BioMérieux obtient l'autorisation pour le test BIOFIRE® SPOTFIRE® R/ST Panel Mini BioMérieux BIOFIRE SPOTFIRE 510(k) CLIA Point Of Care
BRIEF published on 06/26/2024 at 07:06, 2 months 22 days ago BioMérieux Receives FDA Clearance and CLIA-Waiver for BIOFIRE® SPOTFIRE® R/ST Panel Mini BioMérieux FDA Clearance BIOFIRE® SPOTFIRE® CLIA-waiver PCR Test
REGULATED PRESS RELEASE published on 06/26/2024 at 07:01, 2 months 22 days ago bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panel Mini, providing fast syndromic testing solutions for healthcare professionals BioMérieux FDA Clearance Respiratory Infections BIOFIRE SPOTFIRE CLIA-waiver
Published on 09/18/2024 at 23:10, 3 hours 54 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 4 hours 4 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 49 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 6 hours 4 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 34 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 53 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 19 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 32 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 51 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 42 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 18 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 18 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 24 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.